These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38943389)

  • 1. LAM Test: A New Cognitive Marker for Early Detection in Preclinical Alzheimer's Disease.
    García-Martínez M; Pozueta-Cantudo A; Lage C; Martínez-Dubarbie F; López-García S; Fernández-Matarrubia M; Corrales-Pardo A; Bravo M; Cavada NC; Anuarbe P; Infante J; López-Higuera JM; Rodríguez-Cobo L; Rodríguez-Rodríguez E; Butler CR; Sánchez-Juan P
    J Alzheimers Dis; 2024; 100(3):1039-1053. PubMed ID: 38943389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Automatized FACEmemory® scoring is related to Alzheimer's disease phenotype and biomarkers in early-onset mild cognitive impairment: the BIOFACE cohort.
    Alegret M; Sotolongo-Grau O; de Antonio EE; Pérez-Cordón A; Orellana A; Espinosa A; Gil S; Jiménez D; Ortega G; Sanabria A; Roberto N; Hernández I; Rosende-Roca M; Tartari JP; Alarcon-Martin E; de Rojas I; Montrreal L; Morató X; Cano A; Rentz DM; Tárraga L; Ruiz A; Valero S; Marquié M; Boada M
    Alzheimers Res Ther; 2022 Mar; 14(1):43. PubMed ID: 35303916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study.
    Porter T; Burnham SC; Milicic L; Savage G; Maruff P; Lim YY; Li QX; Ames D; Masters CL; Rainey-Smith S; Rowe CC; Salvado O; Groth D; Verdile G; Villemagne VL; Laws SM;
    J Alzheimers Dis; 2018; 66(3):1193-1211. PubMed ID: 30412495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease.
    Sala I; Illán-Gala I; Alcolea D; Sánchez-Saudinós MB; Salgado SA; Morenas-Rodríguez E; Subirana A; Videla L; Clarimón J; Carmona-Iragui M; Ribosa-Nogué R; Blesa R; Fortea J; Lleó A
    J Alzheimers Dis; 2017; 58(3):909-918. PubMed ID: 28527215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early Detection of Learning Difficulties when Confronted with Novel Information in Preclinical Alzheimer's Disease Stage 1.
    Tort-Merino A; Valech N; Peñaloza C; Grönholm-Nyman P; León M; Olives J; Estanga A; Ecay-Torres M; Fortea J; Martínez-Lage P; Molinuevo JL; Laine M; Rodríguez-Fornells A; Rami L
    J Alzheimers Dis; 2017; 58(3):855-870. PubMed ID: 28505969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Memory Correlates of Alzheimer's Disease Cerebrospinal Fluid Markers: A Longitudinal Cohort Study.
    Reijs BLR; Ramakers IHGB; Köhler S; Teunissen CE; Koel-Simmelink M; Nathan PJ; Tsolaki M; Wahlund LO; Waldemar G; Hausner L; Vandenberghe R; Johannsen P; Blackwell A; Vanderstichele H; Verhey F; Visser PJ
    J Alzheimers Dis; 2017; 60(3):1119-1128. PubMed ID: 28984585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive Performance and Cerebrospinal Fluid Markers in Preclinical Alzheimer's Disease: Results from the Gothenburg H70 Birth Cohort Studies.
    Rådestig MA; Skoog J; Zetterberg H; Kern J; Zettergren A; Sacuiu S; Waern M; Wetterberg H; Blennow K; Skoog I; Kern S
    J Alzheimers Dis; 2021; 79(1):225-235. PubMed ID: 33216028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive Variability Predicts Incident Alzheimer's Disease and Mild Cognitive Impairment Comparable to a Cerebrospinal Fluid Biomarker.
    Gleason CE; Norton D; Anderson ED; Wahoske M; Washington DT; Umucu E; Koscik RL; Dowling NM; Johnson SC; Carlsson CM; Asthana S;
    J Alzheimers Dis; 2018; 61(1):79-89. PubMed ID: 29125485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-Out-Test: A New Paradigm for Sorting the Wheat from the Chaff in Prodromal Alzheimer's Disease.
    Torrealba E; Garcia-Morales P; Cejudo JC; Diaz M; Rodriguez-Esparragon F; Fabre O; Mesa-Herrera F; Marin R; Sanchez-Garcia F; Rodriguez-Perez A; Gramunt N
    J Alzheimers Dis; 2019; 67(1):265-277. PubMed ID: 30530971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between Cerebrospinal Fluid Biomarkers for Alzheimer's Disease, APOE Genotypes and Auditory Verbal Learning Task in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.
    Mandecka M; Budziszewska M; Barczak A; Pepłońska B; Chodakowska-Żebrowska M; Filipek-Gliszczyńska A; Nesteruk M; Styczyńska M; Barcikowska M; Gabryelewicz T
    J Alzheimers Dis; 2016 Jul; 54(1):157-68. PubMed ID: 27472875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of the NIA-AA Research Framework: Towards a Biological Definition of Alzheimer's Disease Using Cerebrospinal Fluid Biomarkers in the AIBL Study.
    Burnham SC; Coloma PM; Li QX; Collins S; Savage G; Laws S; Doecke J; Maruff P; Martins RN; Ames D; Rowe CC; Masters CL; Villemagne VL
    J Prev Alzheimers Dis; 2019; 6(4):248-255. PubMed ID: 31686097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychological measures that detect early impairment and decline in preclinical Alzheimer disease.
    Schindler SE; Jasielec MS; Weng H; Hassenstab JJ; Grober E; McCue LM; Morris JC; Holtzman DM; Xiong C; Fagan AM
    Neurobiol Aging; 2017 Aug; 56():25-32. PubMed ID: 28482211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancing the Sensitivity of Memory Tests: Reference Data for the Free and Cued Selective Reminding Test and the Logical Memory Task from Cognitively Healthy Subjects with Normal Alzheimer's Disease Cerebrospinal Fluid Biomarker Levels.
    Brugulat-Serrat A; Cañas-Martínez A; Canals-Gispert L; Marne P; Gramunt N; Milà-Alomà M; Suárez-Calvet M; Arenaza-Urquijo EM; Grau-Rivera O; González-de-Echávarri JM; Minguillon C; Fauria K; Kollmorgen G; Suridjan I; Zetterberg H; Blennow K; Gispert JD; Molinuevo JL; Sánchez-Benavides G;
    J Alzheimers Dis; 2021; 84(1):119-128. PubMed ID: 34569957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linking CSF and cognition in Alzheimer's disease: Reanalysis of clinical data.
    Guhra M; Thomas C; Boedeker S; Kreisel S; Driessen M; Beblo T; Ohrmann P; Toepper M
    Exp Gerontol; 2016 Jan; 73():107-13. PubMed ID: 26585048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid biomarkers and memory present distinct associations along the continuum from healthy subjects to AD patients.
    Rami L; Fortea J; Bosch B; Solé-Padullés C; Lladó A; Iranzo A; Sánchez-Valle R; Molinuevo JL
    J Alzheimers Dis; 2011; 23(2):319-26. PubMed ID: 21098971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal Fluid C18 Ceramide Associates with Markers of Alzheimer's Disease and Inflammation at the Pre- and Early Stages of Dementia.
    Teitsdottir UD; Halldorsson S; Rolfsson O; Lund SH; Jonsdottir MK; Snaedal J; Petersen PH
    J Alzheimers Dis; 2021; 81(1):231-244. PubMed ID: 33814423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitively normal women with Alzheimer's disease proteinopathy show relative preservation of memory but not of hippocampal volume.
    Caldwell JZK; Cummings JL; Banks SJ; Palmqvist S; Hansson O
    Alzheimers Res Ther; 2019 Dec; 11(1):109. PubMed ID: 31878968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Cerebrospinal Fluid S100B Protein with Core Biomarkers and Cognitive Deficits in Prodromal and Mild Alzheimer's Disease.
    Christl J; Verhülsdonk S; Pessanha F; Menge T; Seitz RJ; Kujovic M; Höft B; Supprian T; Lange-Asschenfeldt C
    J Alzheimers Dis; 2019; 72(4):1119-1127. PubMed ID: 31683478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreasing body mass index is associated with cerebrospinal fluid markers of Alzheimer's pathology in MCI and mild dementia.
    Mathys J; Gholamrezaee M; Henry H; von Gunten A; Popp J
    Exp Gerontol; 2017 Dec; 100():45-53. PubMed ID: 29054536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations Between Free and Cued Selective Reminding Test and Cerebrospinal Fluid Biomarkers in Amnestic Mild Cognitive Impairment.
    Giuffrè GM; Quaranta D; Citro S; Morganti TG; Martellacci N; Vita MG; Rossini PM; Calabresi P; Marra C
    J Alzheimers Dis; 2024; 100(2):713-723. PubMed ID: 38905044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.